Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum

Biomedicine and Pharmacotherapy

Volumn 43, Issue 4, 1989, Pages 237-250

  Mathe G ^a   Kidani, Y ^b   Segiguchi, M ^c   Eriguchi, M ^c   Fredj, G ^d   Peytavin, G ^d   Misset, J L ^a   Brienza, S ^a   de Vassals, F ^e   Chenu, E ^a   Bourut, C ^a  

^a Lab 'Rythmes Biologiques C   (France)

^b NAGOYA CITY UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d HÔPITAL PAUL BROUSSE   (France)

^e NONE

Author keywords

l OHP cis platine carboplatinse; l OHP cis platinum carboplatin

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; OXALIPLATIN;

CANCER CHEMOTHERAPY; CLINICAL ARTICLE; COLORECTAL CANCER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; STOMACH CANCER;

ANIMAL; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CISPLATIN; COMPARATIVE STUDY; DRUG EVALUATION; FLUOROURACIL; HUMAN; MICE; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; ORGANOPLATINUM COMPOUNDS; PAPIO;

EID: 0024407292     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/0753-3322(89)90003-6     Document Type: Article

References (45)

1. Preclinical trial in baboon and phase I–II trial and pharmacokinetics in man of malonato-platinum
2. Carboplatin and recurrent childhood brain tumours
3. Notes on the cardiotoxicity of platinum complexes (except l-OHP) in ultrastructural study
4. Proposal for ethical standards in therapeutic trials
5. Weekly 5-fluorouracil (F) versus combination chemotherapy for advanced gastrointestinal carcinomas : a prospective study program
6. Phase I studies with carboplatin at the Royal Marsden Hospital
7. Early clinical studies with cis-diammine-1, 1-cyelobutane dicarboxylate platinum II
8. Cancer Treatment Symposia
9. Carboplatin: the clinical spectrum to date
10. Mutagenic activity of some platinum complexes chemical properties and biological activity
11. Mechanisms of resistance to platinum drugs
12. Phase II trial of carboplatin in patients with adenocarcinomas of the upper gastrointestinal tract
13. Phase I study of l-diamino cyclohexane-oxalatoplatinum (1-OHP) in patients with advanced solid tumors
14. Results of NCI-sponsored phase I trials with carboplatin
15. Carboplatin and 120 hours 5-fluorouracil in patients with colorectal cancer
16. Priming reduces the bone marrow toxicity of carboplatin
17. Phase II study of intraarterial carboplatin and 5-fluorouracil 5-day infusion in liver metastasis from colorectal cancer
18. A coordination chemical approach to prepare organ-specific antitumor platinum complexes in cancer chemotherapy
19. Phase I study of cis-diamminedichloroplatinum (II) administered as a constant 5-day infusion
20. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid
21. Correlation between oncostatic, differenciating, immunologic and virostatic agents and actions. I. Experimental study
22. Phase I trial of oxalato-platinum (l-OHP): a new trial design with dose escalation in each patient
23. Antitumor activity of l-OHP in mice
24. A phase I trial of trans-1diamino-cyclohexane oxalato-platinum (l-OHP)
25. Phase I study and pharmacokinetics of intraperitoneal carboplatin
26. A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diamino) (1-cyclobutanedicarboxylato)-platinum (II) and cis-dianuninedichloroplatinum (II on L1210 cells
27. 5-fluorouracil (5Fu) and cis-platinum (CDDP) chemotherapy for advanced colorectal cancer : a phase II trial
28. Nippon Kayaku
29. CBDCA (NSC-241240): phase II evaluation in metastatic colorectal carcinoma
30. Carboplatin for advanced colorectal carcinoma: a phase II study
31. Phase I study of cis-dichloro-trans-dihydroxy-bis (isopropylamine) platinum IV (CHIP)
32. Preclinical anti-tumor and toxicologic profile of carboplatin
33. Platinum compounds: a new class of potent antitumor agents
34. Characteristics of clinical and experimental resistance to cisplatin
35. Treatment of metastatic colorectal carcinoma with cis-platinum (DDP) and 5-fluorouracil (5Fu)
36. Antitumor activity of new platinum complex, oxalato(trans-1-1,2-diaminocyclohexane)platinum (II)
37. Carboplatin: a preliminary review of its pharroacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer
38. Cisplatin and new platinum analogs